United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. The company offers HemoStyp, which derives from all natural, regenerated oxidized cellulose and designed to absorb exudate and drainage from superficial wounds and help control bleeding. Its customers include hospitals, clinics and physicians, home care providers, municipalities and government agencies and nursing homes and assisted living environments. The company was founded on February 28, 1997 and is headquartered in Henderson, NV.
Company profile
Ticker
UEEC
Exchange
Website
CEO
Douglas K. Beplate
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Zimmer Biomet • Enovis • Steris • Intuitive Surgical • Edwards Lifesciences • Avanos Medical • MSA Safety • INVACARE • Align Technology • Surgalign ...
Former names
MNS EAGLE EQUITY GROUP III INC, United EcoEnergy Corp.
SEC CIK
Corporate docs
IRS number
841517723
UEEC stock data
Latest filings (excl ownership)
10-K
2023 FY
Annual report
1 Apr 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
S-8
Registration of securities for employees
12 Jun 23
10-Q
2023 Q1
Quarterly report
8 May 23
10-K
2022 FY
Annual report
28 Mar 23
8-K
United Health Products Provides Update on FDA PMA Application and Amendment to White Lion Agreement
31 Jan 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
S-8
Registration of securities for employees
20 Oct 22
424B3
Prospectus supplement
23 Sep 22
Latest ownership filings
4
Brian David Thom
17 May 23
144
Notice of proposed sale of securities
10 May 23
4
Brian David Thom
21 Apr 23
5
Kristofer Heaton
3 Feb 23
4
Brian David Thom
17 Jan 23
5
Brian David Thom
17 Jan 23
4
Brian David Thom
20 Sep 22
4
Brian David Thom
8 Jun 22
4/A
Brian David Thom
10 May 22
4
Brian David Thom
6 May 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 74.04 k | 74.04 k | 74.04 k | 74.04 k | 74.04 k | 74.04 k |
Cash burn (monthly) | 19.85 k | 1.89 k | 150.15 k | 211.12 k | 201.59 k | 153.55 k |
Cash used (since last report) | 131.94 k | 12.55 k | 997.85 k | 1.40 mm | 1.34 mm | 1.02 mm |
Cash remaining | -57.90 k | 61.49 k | -923.81 k | -1.33 mm | -1.27 mm | -946.39 k |
Runway (months of cash) | -2.9 | 32.6 | -6.2 | -6.3 | -6.3 | -6.2 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 May 23 | Brian David Thom | Common shares | Sell | Dispose S | No | No | 0.19 | 300,000 | 57.00 k | 1,054,671 |
17 Apr 23 | Brian David Thom | Common Shares | Grant | Acquire A | No | No | 0.22 | 309,375 | 68.06 k | 1,354,671 |
13 Jan 23 | Brian David Thom | Common Shares | Grant | Acquire A | No | No | 0.27 | 225,000 | 60.75 k | 920,296 |
23 Dec 22 | Brian David Thom | Common Shares | Sell | Dispose S | No | No | 0.21 | 201,400 | 42.29 k | 695,296 |
21 Dec 22 | Brian David Thom | Common Shares | Sell | Dispose S | No | No | 0.23 | 98,600 | 22.68 k | 695,296 |
28 Oct 22 | Kristofer Heaton | Common Shares | Sell | Dispose S | No | No | 0.315 | 5,000 | 1.58 k | 1,368,416 |
25 Oct 22 | Kristofer Heaton | Common Shares | Sell | Dispose S | No | No | 0.29 | 4,500 | 1.31 k | 1,373,416 |
16 Sep 22 | Kristofer Heaton | Common Shares | Grant | Acquire A | No | No | 0.3 | 125,000 | 37.50 k | 1,377,916 |
4 May 22 | Kristofer Heaton | Common Shares | Grant | Acquire A | No | No | 0.42 | 250,000 | 105.00 k | 1,252,916 |